Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
4.270
+0.080 (1.91%)
At close: Jul 3, 2025, 1:00 PM
4.310
+0.040 (0.94%)
After-hours: Jul 3, 2025, 4:59 PM EDT
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.02 billion as of July 3, 2025. Its market cap has decreased by -30.58% in one year.
Market Cap
1.02B
Enterprise Value
989.30M
1-Year Change
-30.58%
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.02B, an increase of 320.94%. That is a compound annual growth rate of 13.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 1.02B | -14.93% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |